Vcanbio Cell & Gene Engineering Corp

Vcanbio Cell & Gene Engineering Corp EBITDA

The EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vcanbio Cell & Gene Engineering Corp (600645.SS) as of Sep 21, 2026 is 196.55 M CNY. In the previous year, EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) was 230.12 M CNY — a change of -14.59% (lower).

EBITDA

196.55 MCNY

YoY

-14.59%

Last updated:

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vcanbio Cell & Gene Engineering Corp is 2026 196.55 M CNY. EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vcanbio Cell & Gene Engineering Corp was 2025 230.12 M CNY. It decreases by -14.59% lower compared to the previous year.

The Vcanbio Cell & Gene Engineering Corp EBITDA history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

EBITDA
Date
EBITDA
Jan 1, 2018
110.86 M CNY
Jan 1, 2019
176.53 M CNY
Jan 1, 2020
-19.19 M CNY
Jan 1, 2021
307.82 M CNY
Jan 1, 2022
241.17 M CNY
Jan 1, 2023
219.91 M CNY
Jan 1, 2024
230.12 M CNY
Jan 1, 2025
196.55 M CNY
The Vcanbio Cell & Gene Engineering Corp EBITDA history
YEAREBITDAYoY
196.55 MCNY-14.59%
230.12 MCNY+4.65%
219.91 MCNY-8.82%
241.17 MCNY-21.65%
307.82 MCNY-1,704.31%
-19.19 MCNY-110.87%
176.53 MCNY+59.23%
110.86 MCNY-14.80%
130.12 MCNY+18.67%
109.64 MCNY-60.89%
280.38 MCNY+264.41%
76.94 MCNY—
Access this data via the Eulerpool API
Get Free API Key

Vcanbio Cell & Gene Engineering Corp Stock analysis

What does Vcanbio Cell & Gene Engineering Corp do? Vcanbio Cell & Gene Engineering Corp is one of the most popular companies on Eulerpool.

Frequently Asked Questions about Vcanbio Cell & Gene Engineering Corp stock

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vcanbio Cell & Gene Engineering Corp is 196.55 M CNY in 2026.

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) of Vcanbio Cell & Gene Engineering Corp changed from 230.12 M CNY to 196.55 M CNY, representing a -14.59% change. The value is lower than the previous year.

On Eulerpool you can find the complete historical development of EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization) Vcanbio Cell & Gene Engineering Corp since 2006 – with annual values, charts, and detailed analysis.

EBITDA measures operating performance before the impact of financial structure, tax environment, and non-cash depreciation charges.

EBITDA = EBIT + Depreciation & Amortization

EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s CNY is a key factor for investors. Changes in this metric can signal improving or deteriorating fundamentals, directly impacting the stock price. On Eulerpool, you can track EBITDA (Earnings Before Interest, Taxes, Depreciation & Amortization)'s Vcanbio Cell & Gene Engineering Corp historically and in real time.

Access this data via the Eulerpool API
Get Free API Key

Income Statement — Vcanbio Cell & Gene Engineering Corp

RevenueGross ProfitEBITEBITDANet IncomeEPSCost of Goods SoldR&D ExpensesSG&A ExpensesOperating ExpensesInterest ExpensePretax IncomeTax ExpenseDepreciation & AmortizationRevenue per ShareEBIT per ShareDiluted EPSEBITDA per ShareOther Income/Expense

All Key Metrics — Vcanbio Cell & Gene Engineering Corp